Juha Kere

Juha Kere

Auto-generated profile, based on publicly available information

Juha Kere

Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LRLovisa E. Reinius
Lovisa E. Reinius
NANathalie Acevedo
Nathalie Acevedo
MJMaaike Joerink
Maaike Joerink
GPGöran Pershagen
Göran Pershagen
SDSven-Erik Dahlén
Sven-Erik Dahlén
JKJuha Kere
Juha Kere
Methylation of cytosines at CpG sites is a common epigenetic DNA modification that can be measured by a large number of methods, now even in a genome-wide manner for hundreds of thousands of sites. The application of DNA methylation analysis is becoming widely popular in complex disorders, for example, to understand part of the “missing heritability”. The DNA samples most readily available for methylation studies are derived from whole blood. However, blood consists of many functionally and developmentally distinct cell populations in varying proportions. We studied whether such variation might affect the interpretation of methylation studies based on whole blood DNA. We found in healthy male blood donors there is important variation in the methylation profiles of whole blood, mononuclear cells, granulocytes, and cells from seven selected purified lineages. CpG methylation between mononuclear cells and granulocytes differed for 22% of the 8252 probes covering the selected 343 genes implicated in immune-related disorders by genome-wide association studies, and at least one probe was differentially methylated for 85% of the genes, indicating that whole blood methylation results might be unintelligible. For individual genes, even if the overall methylation patterns might appear similar, a few CpG sites in the regulatory regions may have opposite methylation patterns (i.e., hypo/hyper) in the main blood cell types. We conclude that interpretation of whole blood methylation profiles should be performed with great caution and for any differences implicated in a disorder, the differences resulting from varying proportions of white blood cell types should be considered.

20 January 2013 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
YLYun Liu
Yun Liu
MAMartin J Aryee
Martin J Aryee
LPLeonid Padyukov
Leonid Padyukov
MFM Daniele Fallin
M Daniele Fallin
EHEspen Hesselberg
Espen Hesselberg
AFAndrew P Feinberg
Andrew P Feinberg
Liu et al. use mediation analysis to find changes in DNA methylation that mediate the genetic risk for rheumatoid arthritis. Epigenetic mechanisms integrate genetic and environmental causes of disease, but comprehensive genome-wide analyses of epigenetic modifications have not yet demonstrated robust association with common diseases. Using Illumina HumanMethylation450 arrays on 354 anti-citrullinated protein antibody–associated rheumatoid arthritis cases and 337 controls, we identified two clusters within the major histocompatibility complex (MHC) region whose differential methylation potentially mediates genetic risk for rheumatoid arthritis. To reduce confounding factors that have hampered previous epigenome-wide studies, we corrected for cellular heterogeneity by estimating and adjusting for cell-type proportions in our blood-derived DNA samples and used mediation analysis to filter out associations likely to be a consequence of disease. Four CpGs also showed an association between genotype and variance of methylation. The associations for both clusters replicated at least one CpG (P < 0.01), with the rest showing suggestive association, in monocyte cell fractions in an independent cohort of 12 cases and 12 controls. Thus, DNA methylation is a potential mediator of genetic risk.

11 November 2012 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LTLam Tsoi
Lam Tsoi
SSSarah L Spain
Sarah L Spain
JKJo Knight
Jo Knight
EEEva Ellinghaus
Eva Ellinghaus
PSPhilip E Stuart
Philip E Stuart
RTRichard C Trembath
Richard C Trembath
Richard Trembath and colleagues report a meta-analysis of genome-wide association studies for psoriasis, including 2 cohorts genotyped on the custom Immunochip array, in a total of 10,588 cases and 22,806 controls. They identify 15 new susceptibility loci and refine signals in previously known loci, highlighting a role for innate host defense in susceptibility to psoriasis. To gain further insight into the genetic architecture of psoriasis, we conducted a meta-analysis of 3 genome-wide association studies (GWAS) and 2 independent data sets genotyped on the Immunochip, including 10,588 cases and 22,806 controls. We identified 15 new susceptibility loci, increasing to 36 the number associated with psoriasis in European individuals. We also identified, using conditional analyses, five independent signals within previously known loci. The newly identified loci shared with other autoimmune diseases include candidate genes with roles in regulating T-cell function (such as RUNX3, TAGAP and STAT3). Notably, they included candidate genes whose products are involved in innate host defense, including interferon-mediated antiviral responses (DDX58), macrophage activation (ZC3H12C) and nuclear factor (NF)-κB signaling (CARD14 and CARM1). These results portend a better understanding of shared and distinctive genetic determinants of immune-mediated inflammatory disorders and emphasize the importance of the skin in innate and acquired host defense.

1 April 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
BJBonnie Joubert
Bonnie Joubert
JFJanine F. Felix
Janine F. Felix
PYPaul Yousefi
Paul Yousefi
KBKelly M. Bakulski
Kelly M. Bakulski
AJAllan Just
Allan Just
SLStephanie London
Stephanie London

29 July 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MLMin Ae Lee-Kirsch
Min Ae Lee-Kirsch
MGMaolian Gong
Maolian Gong
DCDipanjan Chowdhury
Dipanjan Chowdhury
LSLydia Senenko
Lydia Senenko
KEKerstin Engel
Kerstin Engel
NHNorbert Hübner
Norbert Hübner

1 August 1996 in Nature Genetics
Verified
Journal Article
Closed access
JKJuha Kere
Juha Kere
ASAnand K. Srivastava
Anand K. Srivastava
OMOuti Montonen
Outi Montonen
JZJonathan Zonana
Jonathan Zonana
NTNick Thomas
Nick Thomas
DSDavid Schlessinger
David Schlessinger